Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J STD AIDS. 2014 Apr;25(5):341-7. doi: 10.1177/0956462413507442. Epub 2013 Oct 7.

Cost analysis and benefits of opt-out HIV testing at a tertiary care centre in northern India.

Author information

1
Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

Currently, in India, the National AIDS Control Organization does not recommend HIV screening for all patients attending health care facilities. The objective of study was to evaluate cost and benefits of opt-out HIV testing at a tertiary care hospital from India. This is a retrospective cohort study of patients who had undergone HIV testing. The cost for HIV testing and cost per HIV-infected patient were determined. A total of 6512 patients (66.4% men and 905 patients younger than 14 years) with mean (SD) age of 30.3 (20.7) years were tested for HIV infection during the study period. Overall, 137 (2.1%) patients tested positive for HIV infection. Total cost for performing HIV tests during study period was Indian Rupees (INR) 649,319 (US dollar [USD] 11805.8). The estimated cost per person tested was INR 99.71 (USD1.8) and cost per HIV-infected patient identified and referred to the antiretroviral therapy centre was INR 4739.55 (USD86.2). We determined a 2.1% period prevalence estimate for HIV infection. Based on cost per HIV-infected patient identified and referred to the antiretroviral therapy centre and the burden of HIV infection, it may be cost effective to perform routine opt-out screening for HIV infection in all patients attending health care facilities in developing countries like India.

KEYWORDS:

AIDS; HIV; India; cost analysis; diagnosis; hospital-based; opt-out screening

PMID:
24100284
DOI:
10.1177/0956462413507442
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center